Sample_Id	Civic_Disease	Hugo_Symbol	Alteration	CIViC_Matching_Disease	CIViC_Matching_Type	CIViC_Matching_Variant	Predictive:N:C	Predictive:N:D	Predictive:P:B	Predictive:P:C	Predictive:P:D	Prognostic:N:B	Prognostic:P:B
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	ERBB2	Amplification	Lung Non-small Cell Carcinoma;Lung Adenocarcinoma	A;A	AMPLIFICATION;AMPLIFICATION	Gefitinib|Erlotinib				Trastuzumab Emtansine		
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	MET	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Adenocarcinoma;Lung Adenocarcinoma;Lung Non-small Cell Carcinoma;Lung Adenocarcinoma;Lung Non-small Cell Carcinoma;Cancer	A;A;A;A;A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION	Erlotinib|Gefitinib	Gefitinib		Crizotinib;Crizotinib;Crizotinib;Crizotinib;Crizotinib	Crizotinib		
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	EGFR	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION		Rociletinib|Osimertinib	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Gefitinib|Erlotinib;Gefitinib|Erlotinib				
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	EGFR	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION		Rociletinib|Osimertinib	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Gefitinib|Erlotinib;Gefitinib|Erlotinib				
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	EGFR	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION		Rociletinib|Osimertinib	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Gefitinib|Erlotinib;Gefitinib|Erlotinib				
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	CCND1	Amplification	Lung Non-small Cell Carcinoma	A	AMPLIFICATION						Y	
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	EGFR	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION		Rociletinib|Osimertinib	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Gefitinib|Erlotinib;Gefitinib|Erlotinib				
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	EGFR	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION		Rociletinib|Osimertinib	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Gefitinib|Erlotinib;Gefitinib|Erlotinib				
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	CCND1	Amplification	Lung Non-small Cell Carcinoma	A	AMPLIFICATION						Y	
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	EGFR	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION		Rociletinib|Osimertinib	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Gefitinib|Erlotinib;Gefitinib|Erlotinib				
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	EGFR	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION		Rociletinib|Osimertinib	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Gefitinib|Erlotinib;Gefitinib|Erlotinib				
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	EGFR	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION		Rociletinib|Osimertinib	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Gefitinib|Erlotinib;Gefitinib|Erlotinib				
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	EGFR	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION		Rociletinib|Osimertinib	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Gefitinib|Erlotinib;Gefitinib|Erlotinib				
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	EGFR	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION		Rociletinib|Osimertinib	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Gefitinib|Erlotinib;Gefitinib|Erlotinib				
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	EGFR	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION		Rociletinib|Osimertinib	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Gefitinib|Erlotinib;Gefitinib|Erlotinib				
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	EGFR	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION		Rociletinib|Osimertinib	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Gefitinib|Erlotinib;Gefitinib|Erlotinib				
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	EGFR	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION		Rociletinib|Osimertinib	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Gefitinib|Erlotinib;Gefitinib|Erlotinib				
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	FGFR1	Amplification	Lung Non-small Cell Carcinoma;Cancer;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION			Dovitinib		PD173074	Y	Y
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	EGFR	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION		Rociletinib|Osimertinib	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Gefitinib|Erlotinib;Gefitinib|Erlotinib				
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	EGFR	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION		Rociletinib|Osimertinib	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Gefitinib|Erlotinib;Gefitinib|Erlotinib				
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	EGFR	Amplification	Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION		Rociletinib|Osimertinib	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Gefitinib|Erlotinib;Gefitinib|Erlotinib				
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	PDGFRA	Amplification	Lung Non-small Cell Carcinoma	A	AMPLIFICATION					Sunitinib		
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	SMARCA4	Deletion	Lung Non-small Cell Carcinoma	B	LOSS					Abemaciclib|Palbociclib		
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	PTEN	Deletion	Cancer;Cancer	B;B	LOSS;LOSS			Buparlisib+Carboplatin+Paclitaxel		Capivasertib		
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	FGFR1	Amplification	Lung Non-small Cell Carcinoma;Cancer;Lung Non-small Cell Carcinoma;Lung Non-small Cell Carcinoma	A;A;A;A	AMPLIFICATION;AMPLIFICATION;AMPLIFICATION;AMPLIFICATION			Dovitinib		PD173074	Y	Y
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	CCND1	Amplification	Lung Non-small Cell Carcinoma	A	AMPLIFICATION						Y	
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	CCND1	Amplification	Lung Non-small Cell Carcinoma	A	AMPLIFICATION						Y	
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	ERBB2	Amplification	Lung Non-small Cell Carcinoma;Lung Adenocarcinoma	A;A	AMPLIFICATION;AMPLIFICATION	Gefitinib|Erlotinib				Trastuzumab Emtansine		
A-Tumor	Lung Cancer|Lung Carcinoma|Lung Non-small Cell Carcinoma|Lung Adenocarcinoma|Solid Tumor|Cancer	AKT2	Amplification	Lung Adenocarcinoma	A	AMPLIFICATION				Vandetanib+Everolimus			
